Pharmacogenomics

Current Drug Metabolism

Volumn 9, Issue 3, 2008, Pages 207-212

  Gomase, Virendra S ^a   Tagore, Somnath ^a   Changbhale, Smruti S ^a   Kale, Karbhari V ^b  

^a PADMASHREE DR D Y PATIL UNIVERSITY   (India)

^b DR BABASAHEB AMBEDKAR MARATHWADA UNIVERSITY   (India)

Author keywords

CE; GC; HPLC; MS; Pharmacogenomics

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AMPHOTERICIN; ANTIMONY; AZATHIOPRINE; CYTOCHROME; FLUOXETINE; MILTEFOSINE; PENTAMIDINE; SPARTEINE; TAMOXIFEN;

AUTOIMMUNE DISEASE; BREAST CANCER; CAPILLARY ELECTROPHORESIS; DEPRESSION; DOSIMETRY; DRUG APPROVAL; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; DRUG URINE LEVEL; FUNCTIONAL GENOMICS; GAS CHROMATOGRAPHY; GENE MUTATION; GENETIC DATABASE; GENETIC VARIABILITY; HEALTH CARE COST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONAL THERAPY; HUMAN; HUMAN GENOME PROJECT; LEUKEMIA; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHARMACOGENOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN LEISHMANIASIS; TOXICOGENETICS; TRANSCRIPTOMICS; UNSPECIFIED SIDE EFFECT; VACCINE PRODUCTION; ANIMAL; GENE EXPRESSION PROFILING; GENOMICS; PHARMACOGENETICS;

ANIMALS; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CAPILLARY; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PHARMACOGENETICS;

EID: 42449114951     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008783884830     Document Type: Review

References (38)

1. Lanfear, D.E. and McLeod, H.L. (2007) Am. Fam. Physician., 76(8), 1179-1182.
2. Kasper, C.E. (2007) Annu. Rev. Nurs. Res., 25, 191-217.
3. Veenstra, D.L. (2000) AAPS PharmSci., 2 (1), 4.
4. Motulsky, A.G. (2000) Am. J. Hum. Genet., 66, 1190-1191.
5. Motulsky, A.G. (2002) J. Hist. Med., 14, 683-705.
6. Thorisson, G.A. and Stein, L.D. (2003) Nucleic Acids Res., 31(1), 124-127.
7. Buetow, K.H.; Edmonson, M.; MacDonald, R.; Clifford, R.; Yip, P.; Kelley, J.; Little, D.P.; Strausberg, R.; Koester, H.; Cantor, C.R.; Braun, A. (2001) PNAS, 98(2), 581-584.
8. Drysdale, C.M.; McGraw, D.W.; Stack, C.B.; Stephens, J.C.; Judson, R.S.; Nandabalan, K.; Arnold, K.; Ruano, G.; Liggett, S.B. (2000) PNAS, 97(19), 10483-10488.
9. Come, S.E.; Buzdar, A.U.; Ingle, J.N.; Arteaga, C.L.; Brown, M., Dowsett, M.; Hilsenbeck, S.G.; Kumar, R.; Johnston, S.R.; Lee, A.V.; Paik, S.; Pritchard, K.I.; Winer, E.P.; Hart, C. (2006) Clin. Cancer Res., 12(3-2), 997s-1000s.
10. Flexner, C. (2007) Nat. Rev. Drug Discov., 6(12), 959-966.
11. Ameen, M. (2007) Expert Opin. Pharmacother., 8(16), 2689-2699.
12. Leeder, J.S.; Mitchell, A.A. (2007) Clin. Pharmacol. Ther., 81(4), 595-599.
13. Martin, R.; Rose, D.; Yu, K.; Barros, S. (2006) Pharmacogenomics, 7(7), 1003-1016.
14. Swan, G.E.; Benowitz, N.L.; Jacob, P.; Lessov, C.N.; Tyndale, R,F.; Wilhelmsen, K.; Krasnow, R.E.; McElroy, M.R.;. Moore, S.E.; Warnbach, M. (2004) Twin. Res., 7(5), 435-448.
15. Holomán, J.; Glasam J.; Veningerová, M.; Prachar, V.; Lukácsová, M. (1997) Bratisl. Lek. Listy., 98(2), 86-90.
16. Frueh, F.W. and Noyer-Weidner, M. (2003) Clin. Chem. Lab. Med., 41(4), 452-461.
17. Gong, Y.; Beitelshees, A.L.; Wessel, J.; Langace, T.Y.; Schork, N.J.; Johnson, J.A. (2007) Pharmacogenet. Genomics. 17(4), 267-75.
18. Tobler, A.R.; Short, S.; Andersen, M.R.; Paner, T.M.; Briggs, J.C.; Lambert, S.M.; Wu, P.P.; Wang, Y.; Spoonde, A.Y.; Koehler, R.T.; Peyret, N.; Chen, C.; Broomer, A.J.; Ridzon, D.A.; Zhou, H.; Hoo, B.S.; Hayashibara, K.C.; Leong, L.N.; Ma, C.N.; Rosenblum, B.B.; Day, J.P.; Ziegle, J.S.; De La Vega, F.M.; Rhodes, M.D.; Hennessy, K.M.; Wenz, H.M. (2005) J. Biomol, Tech., 46(4), 398-406.
19. Peters, E.J.; Slager, S.L.; McGrath, P.J.; Knowles, J.A.; Hamilton, S.P. (2004) Mol Psychiatr., 9(9), 879-889.
20. Lindon, J.C.; Holmes, E.; Nicholson, J.K. (2007) FEBS J., 274(5), 1140-1151.
21. Griffin, J.L.; Scott, J.; Nicholson, J.K. (2007) J. Proteome Res., 6(1), 54-61.
22. Mauger, F.; Jaunay, O.; Chamblain, V.; Reichert, F.; Bauer, K.; Gut, I.G.; Gelfand, D.H. (2006) Nucleic Acids Res., 34(3), e18.
23. Bai, X.; Edwards, J. and Ju, J. (2005) Expert Rev. Mol. Diagn., 5(5), 797-808.
24. Lazarou, J.; Pomeranz, B.H.; Corey. P.N. (1998) JAMA, 279(15), 1200-1205.
25. Hodgson, J.; Marshall. A. (1998) Nat. Biotechnol., 16, 243-246.
26. Pistoi, S. (2002) Scientific American, http://www.greedybrain.com.
27. Keun, H.C. (2006) Pharmacol Ther., 109(1-2), 92-106.
28. Harrigan, G.G.; Brackett, D.J.; Boros, L.G. (2005) Mini Rev. Med. Chem., 5(l), 13-20.
29. Lakshmi, P.T. (2007) Bioinformation, 2(1), 8-11.
30. Goetz, M.P. and Ingle, J. (2007) Cancer, 110(11), 2595-2595.
31. Anstey, A. and Lear, J.T. (1998) BioDrugs., 9(1), 33-47.
32. Buretić-Tomljanović, A. (2007) Psychiatr. Danub., 19(3), 222-230.
33. Moriles Espinosa Mdel, R.; Delgado Sapién, G.; Cravioto, A. (2003) Rev. Latinoam Microbiol., 45(1-2), 24-29.
34. Ospelt, C. and Gay, S. (2006) Arthritis Res. Ther, 8(5), 112.
35. Watters, JW. and McLeod, H.L. (2003) Biochim. Biophys. Acta, 1603(2), 99-111.
36. Chasman, D.I. (2004) JAMA, 291(23), 2821-2827.
37. Mancama, D. and Kerwin, R.W. (200) CNS Drugs, 17(3), 143-151.
38. Anderson, J.L.; Carlquist, J.F.; Horne, B.D.; Muhlestein, J.B. (2003) J. Cardiovasc. Pharmacol. Ther., 8(1), 71-83.